Article: Java’s Chief Scientific Officer Explores Dynamic Data

In this article, Java‘s Dr. James McRedmond ‘explores the ways in which improving the volume, quantity and accuracy of the pharmacodynamic data can add value to clinical trials.’

The full article may be found on the Samedan Ltd Publishers website at the link below: